Q: How does Cannabidivarin (CBDV) work?

Mechanism of Action Cannabidivarin (CBDV) is a naturally occurring compound found in the cannabis plant. Unlike some other cannabinoids, it does not produce intoxicating effects. It primarily functions by interacting with non-classic cannabinoid targets within the body rather than the primary receptors associated with a "high." Interaction with TRP Channels This compound is known to interact with transient receptor potential (TRP) channels. Specifically, it has shown activity at several channels involved in sensory perception, including: TRPV1 TRPV2 TRPA1 These channels play a role in how the body processes pain, temperature, and inflammatory signals. By modulating these channels, the ingredient may influence neurological signaling and cellular excitability. Neurological Effects Research indicates that it may possess anticonvulsant properties. It is thought to reduce seizure activity by affecting the way calcium moves into cells and by inhibiting the cellular uptake of anandamide, a naturally occurring neurotransmitter. Because it has very low affinity for CB1 and CB2 receptors, it does not trigger the typical psychoactive responses associated with cannabis. While these mechanisms are observed in laboratory settings, the exact way it works in humans is still being studied.

Q: Is Cannabidivarin (CBDV) FDA approved?

Investigational Drug Status Cannabidivarin (CBDV) is primarily recognized in the United States as an investigational new drug. It has been the subject of clinical research for various neurological conditions, but it has not received formal approval for any specific therapeutic indication. Because it is undergoing clinical trials, its legal status is distinct from substances that are widely accepted as food ingredients or dietary supplements. Regulatory Oversight and Safety The Food and Drug Administration (FDA) has not evaluated this compound for safety, purity, or effectiveness in a commercial supplement context. Under current federal guidelines, cannabinoids that are studied as drugs before being marketed as supplements generally do not meet the definition of a legal dietary ingredient. Consequently, the ingredient lacks a Generally Recognized as Safe (GRAS) designation for inclusion in food products. Market Availability While various cannabinoid products are available in the marketplace, the regulatory environment remains complex. The quality, concentration, and labeling of products containing this ingredient are not standardized by federal authorities, and these products are not subject to the same rigorous review process as approved pharmaceuticals.

Question 1

What is Cannabidivarin (CBDV)?

Accepted Answer

Cannabidivarin (CBDV) is a non-psychoactive phytocannabinoid derived from the Cannabis sativa plant. As a propyl analogue of cannabidiol (CBD), this compound shares a similar molecular structure but remains a distinct chemical entity. It is often categorized as a minor cannabinoid because it typically appears in lower concentrations than primary compounds like CBD or THC.

This ingredient is found in various hemp and cannabis varieties, particularly in certain landrace strains. While it is a subject of ongoing scientific interest, it does not produce the intoxicating effects commonly associated with other plant-derived cannabinoids.

Question 2

How does Cannabidivarin (CBDV) work?

Accepted Answer

Mechanism of Action

Cannabidivarin (CBDV) is a naturally occurring compound found in the cannabis plant. Unlike some other cannabinoids, it does not produce intoxicating effects. It primarily functions by interacting with non-classic cannabinoid targets within the body rather than the primary receptors associated with a "high."

Interaction with TRP Channels

This compound is known to interact with transient receptor potential (TRP) channels. Specifically, it has shown activity at several channels involved in sensory perception, including:

TRPV1
TRPV2
TRPA1

These channels play a role in how the body processes pain, temperature, and inflammatory signals. By modulating these channels, the ingredient may influence neurological signaling and cellular excitability.

Neurological Effects

Research indicates that it may possess anticonvulsant properties. It is thought to reduce seizure activity by affecting the way calcium moves into cells and by inhibiting the cellular uptake of anandamide, a naturally occurring neurotransmitter. Because it has very low affinity for CB1 and CB2 receptors, it does not trigger the typical psychoactive responses associated with cannabis. While these mechanisms are observed in laboratory settings, the exact way it works in humans is still being studied.

Question 3

Is Cannabidivarin (CBDV) FDA approved?

Accepted Answer

Investigational Drug Status

Cannabidivarin (CBDV) is primarily recognized in the United States as an investigational new drug. It has been the subject of clinical research for various neurological conditions, but it has not received formal approval for any specific therapeutic indication. Because it is undergoing clinical trials, its legal status is distinct from substances that are widely accepted as food ingredients or dietary supplements.

Regulatory Oversight and Safety

The Food and Drug Administration (FDA) has not evaluated this compound for safety, purity, or effectiveness in a commercial supplement context. Under current federal guidelines, cannabinoids that are studied as drugs before being marketed as supplements generally do not meet the definition of a legal dietary ingredient. Consequently, the ingredient lacks a Generally Recognized as Safe (GRAS) designation for inclusion in food products.

Market Availability

While various cannabinoid products are available in the marketplace, the regulatory environment remains complex. The quality, concentration, and labeling of products containing this ingredient are not standardized by federal authorities, and these products are not subject to the same rigorous review process as approved pharmaceuticals.

Question 4

Where can I buy Cannabidivarin (CBDV)?

Accepted Answer

Market Accessibility

Cannabidivarin (CBDV) is a naturally occurring cannabinoid found in the cannabis plant. While it is less common than more prominent compounds like CBD, it has become increasingly available in various commercial markets. This compound is most frequently found in online marketplaces, specialty wellness shops, and certain regional retail outlets.

Common Formulations

The ingredient is typically offered in several different formats to accommodate consumer preferences. These may include:

Oil Tinctures: Liquid extracts often mixed with a carrier oil for sublingual use.
Capsules: Pre-measured doses for oral ingestion.
Isolates: Purified powder forms containing high concentrations of the specific compound.
Topicals: Creams or balms intended for application to the skin.

Product Consistency

Formulations and oversight can differ between manufacturers. Because this ingredient is often derived from hemp plants, its concentration and purity can vary depending on the extraction methods and the specific plant strains used. Availability and regulatory status may vary by region, and consumers often find that product transparency regarding ingredient levels varies between brands.

Cannabidivarin (CBDV)

📋Overview

How It Works

Interactions

Regulatory Status

Availability

Dosage

Frequently Asked Questions

Found an Error?

Find Discounts for Cannabidivarin (CBDV)

Hospitals.net Disclosure